Revance Therapeutics | 销售和管理费用

Name: Revance Therapeutics | 销售和管理费用
Creator: TRADING ECONOMICS
License: https://creativecommons.org/licenses/by/4.0/

	Selling And Administration Expenses	更改		日
Pacira	USD 65.8M		2.15M	2023-12
Supernus Pharmaceuticals	USD 81.28M		1.42M	2023-12

Revance Therapeutics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - May 2024.